Os10g0537100 Antibody

Shipped with Ice Packs
In Stock

Description

Antibody Basics and Functional Relevance

Antibodies are Y-shaped proteins produced by B cells that bind to specific antigens with high precision. Their applications span diagnostics, therapeutics, and research tools .

  • Structure: Composed of two heavy and two light chains, with variable regions (CDRs) determining antigen specificity .

  • Key Functions: Neutralization, agglutination, complement activation, and opsonization .

Hypothetical Context for Os10g0537100 Antibody

The identifier Os10g0537100 suggests a gene locus in Oryza sativa (rice), possibly encoding a protein involved in stress response, growth, or metabolic pathways. Antibodies against such targets are typically used to:

  • Study protein expression via Western blotting or immunohistochemistry .

  • Investigate protein-protein interactions via immunoprecipitation .

Potential Applications

ApplicationMethodologyPurpose
Protein DetectionWestern BlotQuantify Os10g0537100 expression under stress conditions
LocalizationImmunofluorescenceMap subcellular distribution in rice tissues
Functional AnalysisIn Vivo InhibitionDisrupt protein activity to study phenotypic effects

Research Challenges and Validation

Antibody specificity remains a critical issue. For example:

  • Validation Requirements:

    • Knockout (KO) controls to confirm target specificity .

    • Cross-reactivity testing against related proteins .

  • Historical Issues:

    • 50–75% of commercial antibodies fail validation in standardized assays .

Case Study Data

Antibody TypeSuccess Rate (Western Blot)Common Pitfalls
Recombinant75%Low batch variability
Polyclonal40%Non-specific binding
Monoclonal55%Epitope masking

Therapeutic Antibody Development (Comparative Insights)

While Os10g0537100 is not a therapeutic target, approved antibody therapies highlight design principles:

Selected FDA-Approved Antibody Therapeutics

Name (INN)TargetFormatApplication
EculizumabC5Humanized IgG2/IgG4 hybridParoxysmal nocturnal hemoglobinuria
OmalizumabIgEHumanized IgG1Asthma
OfatumumabCD20Human IgG1Chronic lymphocytic leukemia

Key Design Features:

  • Fc modifications (e.g., S228P hinge stabilization) to enhance half-life .

  • Species Origin: Humanized or fully human antibodies reduce immunogenicity .

Recommendations for Future Research

  1. Gene Characterization: Validate Os10g0537100 via CRISPR-Cas9 KO models to confirm phenotypic relevance.

  2. Antibody Production: Use hybridoma or phage display libraries paired with affinity maturation .

  3. Validation Workflow:

    • Step 1: Confirm binding via ELISA with recombinant Os10g0537100 protein.

    • Step 2: Test specificity using KO rice lines .

    • Step 3: Optimize for applications (e.g., flow cytometry, in vivo studies) .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
Os10g0537100 antibody; LOC_Os10g39190 antibody; OSJNBa0040D23.9 antibody; Putative B3 domain-containing protein Os10g0537100 antibody
Target Names
Os10g0537100
Uniprot No.

Target Background

Database Links
Subcellular Location
Nucleus.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.